Literature DB >> 18230904

The role of AMP-activated protein kinase in obesity.

Blerina Kola1, Ashley B Grossman, Márta Korbonits.   

Abstract

AMP-activated protein kinase (AMPK) is a major regulator of energy metabolism at both the cell and at the whole body level. Numerous genetic and obesity models as well as human studies have suggested a role for AMPK in the physiological regulation of fatty acid and glucose metabolism, and in the regulation of appetite. Changes in AMPK activity have been reported in obesity, type 2 diabetes, the metabolic syndrome and cardiovascular disease, which jointly represent a major health and economical problem worldwide. Whether AMPK changes are one of the causes or the consequence of these pathological conditions remains a matter of debate, but AMPK clearly represents a major potential pharmacological target in the treatment of these conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18230904     DOI: 10.1159/000115366

Source DB:  PubMed          Journal:  Front Horm Res        ISSN: 0301-3073            Impact factor:   2.606


  29 in total

1.  Effects of lipoic acid on AMPK and adiponectin in adipose tissue of low- and high-fat-fed rats.

Authors:  Pedro L Prieto-Hontoria; Patricia Pérez-Matute; Marta Fernández-Galilea; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  Eur J Nutr       Date:  2012-06-05       Impact factor: 5.614

2.  CYP1B1 deficiency ameliorates obesity and glucose intolerance induced by high fat diet in adult C57BL/6J mice.

Authors:  Xiaocong Liu; Tingting Huang; Lu Li; Yumeng Tang; Yatao Tian; Suqing Wang; Cuifang Fan
Journal:  Am J Transl Res       Date:  2015-04-15       Impact factor: 4.060

Review 3.  Roles of AMP-activated protein kinase in Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Keshen Li; Sohel H Quazi; Bin Zhao
Journal:  Neuromolecular Med       Date:  2012-02-26       Impact factor: 3.843

4.  Associations between the activity of placental nutrient-sensing pathways and neonatal and postnatal metabolic health: the ECHO Healthy Start cohort.

Authors:  Madeline Rose Keleher; Kathryn Erickson; Katerina Kechris; Ivana V Yang; Dana Dabelea; Jacob E Friedman; Kristen E Boyle; Thomas Jansson
Journal:  Int J Obes (Lond)       Date:  2020-04-23       Impact factor: 5.095

5.  Bromocriptine inhibits adipogenesis and lipogenesis by agonistic action on α2-adrenergic receptor in 3T3-L1 adipocyte cells.

Authors:  Rajib Mukherjee; Jong Won Yun
Journal:  Mol Biol Rep       Date:  2012-12-28       Impact factor: 2.316

6.  Hematopoietic tissue factor-protease-activated receptor 2 signaling promotes hepatic inflammation and contributes to pathways of gluconeogenesis and steatosis in obese mice.

Authors:  Jing Wang; Sagarika Chakrabarty; Quyen Bui; Wolfram Ruf; Fahumiya Samad
Journal:  Am J Pathol       Date:  2014-12-02       Impact factor: 4.307

7.  Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue.

Authors:  X Julia Xu; Marie-Soleil Gauthier; Donald T Hess; Caroline M Apovian; Jose M Cacicedo; Noyan Gokce; Melissa Farb; Rudy J Valentine; Neil B Ruderman
Journal:  J Lipid Res       Date:  2012-02-08       Impact factor: 5.922

8.  Ghrelin in diabetes and metabolic syndrome.

Authors:  Leena Pulkkinen; Olavi Ukkola; Marjukka Kolehmainen; Matti Uusitupa
Journal:  Int J Pept       Date:  2010-04-27

9.  Activation of the AMP-activated protein kinase-p38 MAP kinase pathway mediates apoptosis induced by conjugated linoleic acid in p53-mutant mouse mammary tumor cells.

Authors:  Yung-Chung Hsu; Xiaojing Meng; Lihui Ou; Margot M Ip
Journal:  Cell Signal       Date:  2009-11-20       Impact factor: 4.315

10.  4-1BB signaling activates glucose and fatty acid metabolism to enhance CD8+ T cell proliferation.

Authors:  Beom K Choi; Do Y Lee; Don G Lee; Young H Kim; Seon-Hee Kim; Ho S Oh; Chungyong Han; Byoung S Kwon
Journal:  Cell Mol Immunol       Date:  2016-03-14       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.